First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Kura Oncology, Inc.
Regeneron Pharmaceuticals
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Turning Point Therapeutics, Inc.